ELITE PHARMACEUTICALS, INC /NV/ — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+250.4% +$4M
$5M
Free Cash Flow
$-206K
Investing Cash Flow↑+86.9% +$1M
$-218K
Financing Cash Flow↓-2261.7% -$4M
$-4M
Capex
$206K
Debt Issued
—
Debt Repaid
—
D&A↓-14.2% -$44K
$269K
SBC Allocated Expense↓-36.1% -$25K
$45K
SBC Unrecognized Cost↓-54.4% -$210K
$176K